Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Return on Invested Capital (2020)

Historic Return on Invested Capital for C4 Therapeutics (CCCC) over the last 5 years, with Q4 2024 value amounting to 0.52%.

  • C4 Therapeutics' Return on Invested Capital rose 900.0% to 0.52% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.52%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.52% for FY2024, which is 0.0% changed from last year.
  • Per C4 Therapeutics' latest filing, its Return on Invested Capital stood at 0.52% for Q4 2024, which was up 900.0% from 0.47% recorded in Q2 2024.
  • In the past 5 years, C4 Therapeutics' Return on Invested Capital ranged from a high of 0.37% in Q3 2020 and a low of 0.89% during Q4 2020
  • Over the past 5 years, C4 Therapeutics' median Return on Invested Capital value was 0.5% (recorded in 2024), while the average stood at 0.35%.
  • In the last 5 years, C4 Therapeutics' Return on Invested Capital changed by 0bps in 2022 and then soared by 900bps in 2024.
  • Over the past 5 years, C4 Therapeutics' Return on Invested Capital (Quarter) stood at 0.89% in 2020, then soared by 72bps to 0.25% in 2021, then rose by 2bps to 0.25% in 2022, then tumbled by -149bps to 0.61% in 2023, then increased by 15bps to 0.52% in 2024.
  • Its last three reported values are 0.52% in Q4 2024, 0.47% for Q2 2024, and 0.55% during Q1 2024.